findmyKOL
Clinical trialNCT03941860CompletedPhase 3Interventional

Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial

SponsorNational Cancer Institute (NCI)Enrollment1Multiple Myeloma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

222 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico
  • Centro Comprensivo de Cancer de Upr

    San Juan, Puerto Rico

United States
  • Cancer Center at Saint Joseph'S

    Phoenix, Arizona, United States

  • Chi Saint Vincent Cancer Center Hot Springs

    Hot Springs, Arkansas, United States

  • Mission Hope Medical Oncology - Arroyo Grande

    Arroyo Grande, California, United States

  • Pacific Central Coast Health Center-San Luis Obispo

    San Luis Obispo, California, United States

  • Mission Hope Medical Oncology - Santa Maria

    Santa Maria, California, United States

  • Penrose-Saint Francis Healthcare

    Colorado Springs, Colorado, United States

  • Rocky Mountain Cancer Centers-Penrose

    Colorado Springs, Colorado, United States

  • Adventhealth Porter

    Denver, Colorado, United States

  • Mercy Medical Center

    Durango, Colorado, United States

  • Southwest Oncology Pc

    Durango, Colorado, United States

  • Saint Anthony Hospital

    Lakewood, Colorado, United States

  • Littleton Adventist Hospital

    Littleton, Colorado, United States

  • Longmont United Hospital

    Longmont, Colorado, United States

  • Rocky Mountain Cancer Centers-Longmont

    Longmont, Colorado, United States

  • Parker Adventist Hospital

    Parker, Colorado, United States

  • Saint Mary Corwin Medical Center

    Pueblo, Colorado, United States

  • Rush - Copley Medical Center

    Aurora, Illinois, United States

  • Illinois Cancercare-Bloomington

    Bloomington, Illinois, United States

  • Illinois Cancercare-Canton

    Canton, Illinois, United States

  • Memorial Hospital of Carbondale

    Carbondale, Illinois, United States

  • Sih Cancer Institute

    Carterville, Illinois, United States

  • Illinois Cancercare-Carthage

    Carthage, Illinois, United States

  • Centralia Oncology Clinic

    Centralia, Illinois, United States

  • Carle at the Riverfront

    Danville, Illinois, United States

  • Cancer Care Specialists of Illinois - Decatur

    Decatur, Illinois, United States

  • Decatur Memorial Hospital

    Decatur, Illinois, United States

  • Illinois Cancercare-Dixon

    Dixon, Illinois, United States

  • Carle Physician Group-Effingham

    Effingham, Illinois, United States

  • Crossroads Cancer Center

    Effingham, Illinois, United States

  • Illinois Cancercare-Eureka

    Eureka, Illinois, United States

  • Illinois Cancercare-Galesburg

    Galesburg, Illinois, United States

  • Western Illinois Cancer Treatment Center

    Galesburg, Illinois, United States

  • Illinois Cancercare-Kewanee Clinic

    Kewanee, Illinois, United States

  • Illinois Cancercare-Macomb

    Macomb, Illinois, United States

  • Carle Physician Group-Mattoon/charleston

    Mattoon, Illinois, United States

  • Cancer Care Center of O'Fallon

    O'Fallon, Illinois, United States

  • Illinois Cancercare-Ottawa Clinic

    Ottawa, Illinois, United States

  • Illinois Cancercare-Pekin

    Pekin, Illinois, United States

  • Illinois Cancercare-Peoria

    Peoria, Illinois, United States

182 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Feb 2022
Primary completion
6 Aug 2023
Completion
31 Jan 2025
Last update posted
23 May 2025
Registered enrollment
1
Registry id
NCT03941860

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.